Publications by authors named "Young Heun Jo"
Investig Clin Urol
September 2024
Article Synopsis
- In high-risk non-muscle-invasive bladder cancer (NMIBC), intravesical Bacillus Calmette-Guérin (BCG) is the primary treatment after tumor removal, but intravesical gemcitabine is being considered due to BCG shortages; this study focuses on gemcitabine's effectiveness in the Korean population.
- Researchers analyzed data from 60 patients who received 6 weeks of weekly intravesical gemcitabine after tumor resection, categorizing them into high-risk and very high-risk groups based on established medical criteria.
- Results indicated that the disease-free survival (DFS) rates were similar for both high-risk and very high-risk patients at various follow-up points, suggesting that gemcit
